For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>
Get a Quote
Cilostazol Manufacturer

Cadila Pharmaceuticals Ltd. is an industry leader in synthesizing APIs. We are bulk drug manufacturer of Cilostazol. The CAS number of Cilostazol is 73963-72-1.

Cilostazol is used in the alleviation of the symptoms of intermittent claudication in individuals with peripheral vascular disease. Cilostazol is a phosphodiesterase inhibitor with therapeutic focused on cAMP. It inhibits platelet aggregation and it is a direct arterial vasodilator. Its major effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation.

Cadila Pharmaceuticals Ltd. is one of the USFDA approved pharma contract manufacturing companies in India. It is known as one of the top Active Pharmaceutical Ingredients (APIs) manufacturing company based in India. We synthesize APIs of the superb quality in cost-effective manner.

We are major Cilostazol manufacturer and supplier. We supply peripheral vascular disease drug Cilostazol to domestic market and country like Japan.

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals